Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 9 | 2013 | 100 | 1.570 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2013 | 71 | 0.800 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2011 | 21 | 0.710 |
Why?
|
| Myocardial Ischemia | 3 | 2011 | 85 | 0.680 |
Why?
|
| Aortic Valve | 3 | 2018 | 48 | 0.600 |
Why?
|
| Coronary Disease | 3 | 2007 | 202 | 0.540 |
Why?
|
| Bioprosthesis | 3 | 2018 | 55 | 0.460 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2018 | 41 | 0.450 |
Why?
|
| Postoperative Hemorrhage | 3 | 2013 | 38 | 0.410 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 8 | 0.400 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2018 | 24 | 0.400 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 27 | 0.400 |
Why?
|
| Propofol | 1 | 2011 | 19 | 0.400 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2010 | 9 | 0.360 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 39 | 0.360 |
Why?
|
| Preoperative Care | 2 | 2008 | 110 | 0.350 |
Why?
|
| Heart Diseases | 1 | 2010 | 99 | 0.340 |
Why?
|
| Postoperative Complications | 5 | 2013 | 674 | 0.330 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 23 | 0.330 |
Why?
|
| Treatment Outcome | 11 | 2018 | 3123 | 0.320 |
Why?
|
| Premedication | 1 | 2008 | 10 | 0.320 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.320 |
Why?
|
| Blood Loss, Surgical | 1 | 2008 | 45 | 0.310 |
Why?
|
| Heart Valves | 2 | 2005 | 15 | 0.310 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 85 | 0.300 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 25 | 0.290 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 377 | 0.290 |
Why?
|
| Middle Aged | 16 | 2018 | 10920 | 0.270 |
Why?
|
| Aged | 16 | 2018 | 9572 | 0.270 |
Why?
|
| Aprotinin | 1 | 2005 | 6 | 0.270 |
Why?
|
| Male | 20 | 2018 | 17970 | 0.270 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2005 | 7 | 0.270 |
Why?
|
| Thymus Neoplasms | 1 | 2005 | 4 | 0.270 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 20 | 0.260 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2005 | 13 | 0.260 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 135 | 0.250 |
Why?
|
| Palliative Care | 1 | 2005 | 47 | 0.250 |
Why?
|
| Heart Valve Prosthesis | 2 | 2018 | 53 | 0.240 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2004 | 11 | 0.240 |
Why?
|
| Aneurysm, Dissecting | 1 | 2004 | 12 | 0.240 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2003 | 6 | 0.230 |
Why?
|
| Humans | 22 | 2018 | 29453 | 0.230 |
Why?
|
| Hemoglobins | 1 | 2003 | 43 | 0.230 |
Why?
|
| Enoxaparin | 1 | 2003 | 19 | 0.230 |
Why?
|
| Retrospective Studies | 8 | 2018 | 3135 | 0.230 |
Why?
|
| Blood Transfusion | 1 | 2003 | 64 | 0.220 |
Why?
|
| Female | 16 | 2018 | 18342 | 0.220 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 337 | 0.220 |
Why?
|
| Risk Factors | 8 | 2018 | 3598 | 0.220 |
Why?
|
| Time Factors | 5 | 2018 | 2013 | 0.190 |
Why?
|
| Prognosis | 3 | 2010 | 1369 | 0.180 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2011 | 57 | 0.170 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 43 | 0.160 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 150 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 29 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 25 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2017 | 44 | 0.150 |
Why?
|
| Stents | 1 | 2018 | 171 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 91 | 0.140 |
Why?
|
| Adult | 7 | 2013 | 8513 | 0.140 |
Why?
|
| Survival Rate | 3 | 2010 | 796 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 3758 | 0.130 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 247 | 0.130 |
Why?
|
| Ventricular Function, Left | 3 | 2011 | 198 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2004 | 40 | 0.120 |
Why?
|
| Factor IX | 1 | 2013 | 8 | 0.120 |
Why?
|
| North Carolina | 2 | 2010 | 1428 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2010 | 1328 | 0.110 |
Why?
|
| Cognition Disorders | 2 | 2007 | 391 | 0.110 |
Why?
|
| Heparin | 2 | 2003 | 75 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2011 | 4 | 0.100 |
Why?
|
| Embolism, Cholesterol | 1 | 2011 | 6 | 0.100 |
Why?
|
| Probability | 3 | 2009 | 150 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2009 | 188 | 0.090 |
Why?
|
| Swine | 2 | 2009 | 203 | 0.090 |
Why?
|
| Critical Care | 1 | 2011 | 115 | 0.090 |
Why?
|
| Exercise Test | 1 | 2010 | 194 | 0.090 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2007 | 7 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 2009 | 2 | 0.090 |
Why?
|
| Ranitidine | 1 | 2009 | 2 | 0.090 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2009 | 2 | 0.090 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2009 | 8 | 0.090 |
Why?
|
| Bioreactors | 1 | 2009 | 59 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2011 | 861 | 0.080 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 1 | 0.080 |
Why?
|
| Cross Infection | 1 | 2009 | 46 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 12 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2010 | 440 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2008 | 26 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 244 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 533 | 0.080 |
Why?
|
| Blood Volume | 1 | 2008 | 6 | 0.080 |
Why?
|
| Platelet Transfusion | 1 | 2008 | 16 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2010 | 348 | 0.080 |
Why?
|
| Reoperation | 2 | 2011 | 204 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 32 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2009 | 638 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2009 | 180 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2008 | 2041 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 727 | 0.080 |
Why?
|
| Logistic Models | 2 | 2009 | 729 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 2007 | 20 | 0.070 |
Why?
|
| Prevalence | 1 | 2010 | 910 | 0.070 |
Why?
|
| Incidence | 2 | 2009 | 1126 | 0.070 |
Why?
|
| Animals | 3 | 2009 | 7328 | 0.070 |
Why?
|
| Hematocrit | 1 | 2005 | 23 | 0.070 |
Why?
|
| Age Factors | 2 | 2007 | 1120 | 0.070 |
Why?
|
| Causality | 1 | 2005 | 39 | 0.070 |
Why?
|
| Thymectomy | 1 | 2005 | 1 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2005 | 81 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2005 | 78 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 12 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 90 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 273 | 0.060 |
Why?
|
| Cattle | 1 | 2004 | 100 | 0.060 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 3 | 0.060 |
Why?
|
| Pericardium | 1 | 2004 | 50 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 864 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 105 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 438 | 0.060 |
Why?
|
| Comorbidity | 1 | 2005 | 548 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2007 | 873 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 520 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2004 | 56 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2004 | 137 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2009 | 617 | 0.060 |
Why?
|
| Pipecolic Acids | 1 | 2003 | 6 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2004 | 70 | 0.060 |
Why?
|
| Sepsis | 1 | 2005 | 149 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2003 | 49 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 85 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 32 | 0.060 |
Why?
|
| Disease Progression | 1 | 2005 | 574 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2018 | 148 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 376 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 122 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 641 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 388 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2013 | 1701 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 588 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 87 | 0.040 |
Why?
|
| Punctures | 1 | 2017 | 32 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2018 | 190 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 1057 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2017 | 170 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 295 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 333 | 0.030 |
Why?
|
| Chest Tubes | 1 | 2013 | 6 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 5 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 9 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 16 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 2121 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 249 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 95 | 0.020 |
Why?
|
| Anti-Ulcer Agents | 1 | 2009 | 3 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 12 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 85 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 91 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 129 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 141 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 604 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2008 | 14 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 224 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 199 | 0.020 |
Why?
|
| Sheep | 1 | 2009 | 224 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 91 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2009 | 120 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 20 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 975 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 1171 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 711 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 380 | 0.020 |
Why?
|
| Constriction | 1 | 2005 | 12 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 72 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 39 | 0.020 |
Why?
|
| Epinephrine | 1 | 2005 | 41 | 0.020 |
Why?
|
| Dobutamine | 1 | 2005 | 43 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 55 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2003 | 19 | 0.010 |
Why?
|
| Aorta | 1 | 2003 | 103 | 0.010 |
Why?
|
| Critical Illness | 1 | 2003 | 88 | 0.010 |
Why?
|
| Dopamine | 1 | 2005 | 227 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 468 | 0.010 |
Why?
|